TODAY THERE IS AN EMPHASIS TO IMPROVE QUALITY OF LIFE (QOL) AMONG HF PATIENTS WHILE MANAGING SYMPTOMS, DEFINING THE CLINICAL AND ECONOMIC GOALS.
26 M
HF patients worldwide
6M in U.S.
$ 108 B
Economic burden
$32B in U.S.
74 %
HF patients with
comorbidities
PARTNERSHIPS
We partner with medical device manufacturers to incorporate our technology.
Our team has decades of experience with hardware design, signal processing, algorithm development, and regulatory approval of medical devices.
Audicor technology is designed and developed under ISO 13485 QMS controls.
USE MODELS
Wearable
Implantable
Daily Monitoring
Hospital
TEAM
Peter Bauer
PRESIDENT
Alan Andresen
VP ENGINEERING
Tim Wheeler
CHIEF TECHNOLOGY OFFICER
Patti Arand
DIRECTOR RESEARCH AND ALGORITHMS
Gregg Harris
DIRECTOR QUALITY AND REGULATORY